Marshall Fordyce

Marshall Fordyce, MD is Co-founder, President and Chief Executive Officer of Trucode. He brings more than 10 years of experience leading teams in drug discovery, development, clinical translation, and commercialization. Prior to founding Trucode, he was an entrepreneur in residence at Kleiner Perkins. Previously, Dr. Fordyce served as Senior Director of Clinical Research at Gilead Sciences, where he contributed to seven new drug approvals and served as Project Lead for Gilead’s highly successful TAF/GENVOYA development program. With subspecialty training in infectious disease from Columbia P&S, Dr. Fordyce was previously Chief Resident at NYU Bellevue and spent two years as translational research fellow at Rockefeller University. Dr. Fordyce has been an advisor to Google X and to several private biotech companies. He currently serves on the Board of Directors of the Albert and Mary Lasker Foundation. He received his BA from Harvard University and his MD from Harvard Medical School.